Evid Invest
Holders — by stockHoldings — by fund

Ishara Investments LP

Everything this manager disclosed owning in US-listed stocks — its complete Form 13F portfolio · as of 2026-09-30 · filed with the SEC up to 45 days after quarter end · CIK 0002111609

$121.0M

disclosed book value

40

positions

7.1%

largest position share

Positions, as of 2026-09-30

top 41 of 40 · 13F covers long US-listed positions only — cash, bonds, private and foreign stakes are not disclosed · PUT/CALL tags = options positions (share-equivalents), not shares held

#IssuerSharesValue% of book
1TVTXTRAVERE THERAPEUTICS INC145,000$8.5M7.1%
2CYTKCYTOKINETICS INC128,000$8.4M7%
3BBIOBRIDGEBIO PHARMA INC100,000$6.6M5.4%
4ACADACADIA PHARMACEUTICALS INC320,000$6.4M5.3%
5TARSTARSUS PHARMACEUTICALS INC70,000$5.5M4.5%
6PTCTPTC THERAPEUTICS INC80,000$5.2M4.3%
7PRAXPRAXIS PRECISION MEDICINES I17,000$5.0M4.1%
8VERAVERA THERAPEUTICS INC150,000$4.8M4%
9ARQTARCUTIS BIOTHERAPEUTICS INC180,000$4.8M3.9%
10ANNXANNEXON INC1.1M$4.7M3.9%
11UTHRUNITED THERAPEUTICS CORP DEL8,000$4.3M3.6%
12NAMSNEWAMSTERDAM PHARMA COMPANY160,000$3.9M3.2%
13XERSXERIS BIOPHARMA HOLDINGS INC400,000$3.8M3.2%
14CELCCELCUITY INC48,000$3.8M3.2%
15DBVTDBV TECHNOLOGIES S A270,000$3.2M2.6%
16VRDNVIRIDIAN THERAPEUTICS INC150,000$3.1M2.6%
17ZNTLZENTALIS PHARMACEUTICALS INC1.1M$3.0M2.5%
18BMRNBIOMARIN PHARMACEUTICAL INC48,000$2.9M2.4%
19BIIBBIOGEN INC12,000$2.7M2.2%
20MLYSMINERALYS THERAPEUTICS INC100,000$2.5M2.1%
21LGNDLIGAND PHARMACEUTICALS INC8,000$2.5M2.1%
22RAREULTRAGENYX PHARMACEUTICAL IN160,000$2.4M2%
23PCVXVAXCYTE INC40,000$2.3M1.9%
24ORICORIC PHARMACEUTICALS INC160,000$2.2M1.8%
25AXSMAXSOME THERAPEUTICS INC.10,000$1.8M1.5%
26SLNSILENCE THERAPEUTICS PLC160,000$1.7M1.4%
27BEAMBEAM THERAPEUTICS INC70,000$1.7M1.4%
28BHVNBIOHAVEN LTD120,000$1.6M1.3%
29RAREULTRAGENYX PHARMACEUTICAL INPUT1,000$1.5M1.2%
30CTNMCONTINEUM THERAPEUTICS INC108,000$1.4M1.2%
31GMABGENMAB A/S40,000$1.4M1.2%
32NBIXNEUROCRINE BIOSCIENCES INC8,000$1.1M0.9%
33MNPRMONOPAR THERAPEUTICS INC12,000$956,0400.8%
34MLTXMOONLAKE IMMUNOTHERAPEUTICS80,000$936,0000.8%
35SPRYARS PHARMACEUTICALS INC200,000$862,0000.7%
36IONSIONIS PHARMACEUTICALS INC16,000$714,4000.6%
37OLMAOLEMA PHARMACEUTICALS INC80,000$691,2000.6%
38LXRXLEXICON PHARMACEUTICALS INC320,000$600,0000.5%
39WVEWAVE LIFE SCIENCES INC160,000$592,0000.5%
40SVRASAVARA INC80,000$412,8000.3%
41GOSSGOSSAMER BIO INC24,000$284,4000.2%

Source: SEC Form 13F-HR, reporting period 2026-09-30. Values are the manager's filed June-30-style quarter-end marks, not live prices. Research, not investment advice.

EvidInvest is an independent research and information tool. Figures are calculated from public SEC filings and third-party market data and are provided for informational and educational purposes only. EvidInvest does not provide investment advice, brokerage, or financial services, and is not affiliated with any company it covers. Verify all figures against primary sources before making any decision.